This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top analysts changed outlook on top names. See analyst ratings page for all changes.
Read original at benzingaStocks · News reference
Sinda Ltd Reported Q2 Net Loss Of $(16.6)M Vs $(2.2)M YoY
Reported a net loss of $16.6 million for the three months ended June 30, 2026, compared to a net loss of $2.2 million in the second quarter of 2025. The increase was driven by planned growth in exploration and
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 1:27 PM
- Checked
- Aug 14, 2026, 1:27 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Canaccord Genuity Initiates Coverage On Sinda with Speculative Buy Rating, Announces Price Target of $19
Canaccord Genuity analyst Peter Bell initiates coverage on Sinda (NYSE:SIND) with a Speculative Buy rating and announces Price Target of $19.
Read original at benzingaBMO Capital Maintains Outperform on Sinda, Raises Price Target to $19
BMO Capital analyst Kevin O'Halloran maintains Sinda (NYSE:SIND) with a Outperform and raises the price target from $16 to $19.
Read original at benzingaSinda Q2 EPS $(0.13) Misses $(0.09) Estimate
Read original at benzinga